Sickle Cell Disease Stem Cell Repository
$1,208,891OT2FY2019HLNIH
Boston Children'S Hospital, Boston MA
Investigators
Abstract
We plan to recruit volunteers with SCD as healthy donors for collection of peripheral blood stem cells by apheresis. Volunteers will be treated with plerixafor, a drug that we and others have shown to mobilize peripheral blood (PB) CD34+ cells safely in SCD patients. The collected stem cells will be purified by magnetic separation using CD34 beads, validated, frozen, and then provided as a resource to investigators working on developing therapies for SCD.
View original record on NIH RePORTER →